The Signal Directory

HealthTech executives worth following

Founders, investors, health system and payer leaders, policy people and analysts. Filter by the part of the industry they work in and where they post.

Looking for practising clinicians instead? Open the clinician directory.

Deven McGraw, JD, MPH

Health Privacy and Regulatory Consultant, Devici Group

Policy & Regulation

Follow for essential updates on HIPAA regulations, health data privacy laws, and patient data rights. She translates complex legal frameworks into actionable strategies for digital health teams.

HIPAA Privacy / Health Data Privacy / Data Sharing Rights

Best for: Compliance officers, lawyers, and digital health founders.

Farzad Mostashari, MD, ScM

Co-Founder and CEO, Aledade

Policy & Regulation

Offers invaluable analysis on healthcare delivery reform, value-based care policy, and primary care enablement. He regularly shares practical advice on navigating Medicare rules and clinical workflows.

Value-Based Care / Medicare Reform / Primary Care Policy

Best for: Primary care clinicians and digital health operators.

Grace Cordovano, PhD, BCPA

Board-Certified Patient Advocate, Enlightening Results

Policy & Regulation

Shares critical commentary on digital health equity, information blocking rules, and patient access to records. She champions administrative burden reduction from a patient perspective.

Digital Health Equity / Information Blocking / Patient Advocacy

Best for: Patient advocates and health technology designers.

Kavita Patel, MD, MS

Venture Partner and Nonresident Fellow, Brookings Institution

Policy & Regulation

Follow for expert breakdowns of healthcare legislative reform, physician payment policies, and community medicine programs. She delivers pragmatic updates on federal health programs and policy implementation.

Healthcare Reform / Medicare Policy / Physician Payments

Best for: Health policy researchers and clinical executives.

Lucia Savage, JD

Chief Administration and Legal Officer, Omada Health

Policy & Regulation

Offers deep expertise on digital health regulation, privacy compliance, and health data sharing models. She regularly posts on federal regulatory frameworks affecting digital therapeutics.

Digital Health Law / Privacy Compliance / Federal Frameworks

Best for: Digital health executives and regulatory compliance teams.

Luciana Borio, MD

Venture Partner, ARCH Venture Partners

Policy & Regulation

Provides expert insights on global health security, FDA drug regulation, and pandemic preparedness. Her posts offer deep analysis of national health policies and medical countermeasures.

FDA Drug Regulation / Biosecurity / Pandemic Preparedness

Best for: Healthcare investors, biosecurity analysts, and policy makers.

Mark McClellan, MD, PhD

Director, Duke-Margolis Institute for Health Policy

Policy & Regulation

Provides authoritative discussions on payment models, healthcare delivery reform, and real-world evidence. He offers insights into policies advancing health equity and high-value care systems.

Payment Reform / Healthcare Quality / Real-World Evidence

Best for: Healthcare economists and system administrators.

Michael Sinha, MD, JD, MPH

Assistant Professor of Law, Saint Louis University School of Law

Policy & Regulation

Follow for detailed analysis of FDA regulations, pharmaceutical law, and drug pricing. He provides regular, expert commentary on public health legal updates and regulatory decisions.

FDA Regulation / Pharmaceutical Law / Drug Pricing

Best for: Legal professionals and pharmaceutical developers.

Micky Tripathi, PhD

National Coordinator for Health IT, HHS Office of the National Coordinator

Policy & Regulation

He provides authoritative updates on national electronic health record interoperability standards, health IT policies, and federal digital health strategies aiming to improve patient access.

Interoperability / Health IT Standards / Patient Data Access

Best for: Health IT developers and clinical informatics leaders.

Scott Gottlieb, MD

Resident Fellow, American Enterprise Institute

Policy & Regulation

He delivers timely analysis of drug development pipelines, FDA approval processes, and public health policy. His commentary covers market access trends and pharmaceutical industry updates.

FDA Approval / Drug Development / Public Health Policy

Best for: Biotech executives, investors, and public health analysts.

Showing 10 of 121 people. Listings are editorial, not paid, and nobody pays to appear here.